What do you understand by Fixed Dose Drug Combinations (FDCs)? Discuss their merits and demerits.

What are FDCs?

Fixed Dose Drug Combinations (FDCs) are formulations containing two or more active pharmaceutical ingredients combined in a fixed ratio within a single dosage form, such as a tablet or capsule. Rational FDCs are widely used in tuberculosis, HIV, malaria and hypertension therapy where combined action is medically justified.

Merits

• Improved patient compliance by reducing pill burden, especially in chronic and long-course diseases like TB and HIV.
• Lower overall cost of packaging, distribution and treatment.
• Synergistic or additive therapeutic effect and, in TB/HIV, prevention of drug resistance from mono-therapy.
• Simplified logistics for mass public-health programmes.

Demerits

• Many combinations are pharmacologically irrational, mixing drugs with different half-lives or unrelated actions.
• Fixed ratios prevent individualised dose titration for the elderly, children or renal patients.
• Difficulty in identifying which ingredient caused an adverse reaction.
• Irrational antibiotic FDCs accelerate antimicrobial resistance.

Regulatory response

Acting on the Kokate Committee's findings, the Ministry of Health banned hundreds of irrational FDCs from 2016 onwards, a step upheld with modifications by the Supreme Court. The CDSCO now requires central approval and safety-efficacy data for new combinations.

Conclusion

FDCs are valuable when scientifically rational but hazardous when driven by marketing. Robust regulation, a defined national list and post-marketing surveillance are essential to retain their benefits while curbing misuse.